Psyence Biomedical Ltd. Common Shares (PBM) — Cash Flow Quality Index
Psyence Biomedical Ltd. Common Shares (PBM) has a Cash Flow Quality Index of -0.04x as of December 2022. Operating cash flow of $-86.26K is below net income of $2.25 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Psyence Biomedical Ltd. Common Shares to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Psyence Biomedical Ltd. Common Shares Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Psyence Biomedical Ltd. Common Shares across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see PBM cash generation efficiency.
Annual Cash Flow Quality Index for Psyence Biomedical Ltd. Common Shares (2025–2025)
Year-by-year earnings quality comparison for Psyence Biomedical Ltd. Common Shares.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -3.69x | $-3.73 Million | $1.01 Million | — |